BIOA BioAge Labs, Inc.
$15.48▼ -2.03%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$688.13M
P/E Ratio
–
Div Yield
–%
52W Range
4.07 - 24.00
% vs 50 MA
-8.13%
% vs 200 MA
16.93%
RSI-14
43.1
MACD Histogram
-0.1000
Beta (1Y vs SPY)
1.73
Free Cash Flow
-$24.07M
Gross Rev
$2.77M
Gross Profit
$2.77M
EBITDA
-$22.04M
COGS
–
Operating Exp
$28.15M
Operating Income
-$25.38M
EBIT
-$25.38M
Pretax Income
-$22.25M
Net Income
-$22.25M
EPS (Diluted)
-0.52
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Mar 2026 (Quarterly)
Social Sentiment
Avg +0.75 · 4 posts
Yahoo Finance featured my bullish thesis on $BIOA, via Insider Monkey
r/stocks · Dec 31, 2024
The post indicates a positive view on BIOA due to a Yahoo Finance feature, suggesting bullish sentiment.
positive
+0.30
NewsDDTradeYahoo Finance featured my bullish thesis on $BIOA, via Insider Monkey
r/investing · Dec 31, 2024
The author is actively holding and considering adding to the stock based on positive news and recognition.
positive
+0.80
DDNewsPriceTarget$BIOA
r/wallstreetbets · Oct 21, 2024
The post uses highly positive language ('🔥', 'going to be 🔥') and references the 'Ozempic and Wegovy wagon,' indicating strong bullish sentiment.
very_positive
+1.00
NewsDiscussionTradePriceTarget$LLY backed partner BioAge ($BIOA) testing exercise mimetics together with GLP-1 weight loss drugs.
r/wallstreetbets · Sep 27, 2024
The post focuses on BioAge’s trial results and potential weight loss outcomes, driving significant enthusiasm.
very_positive
+0.90
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.